President Donald Trump keeps on observing a jungle fever medicate, hydroxychloroquine, as a promising medication to be utilized to forestall disease with the coronavirus, the White House said on Thursday, however, the US Food and Drug Administration has said its viability and security were doubtful.

"The president has consistently said that he considers hydroxychloroquine to be a promising prophylactic yet that each individual ought not to take it except if they get medicine from their PCP," White House representative Kayleigh McEnany said at a news meeting.

Donald Trump told correspondents in May he had begun taking hydroxychloroquine after two White House staff members tried positive for COVID-19.

His primary care physician said a month ago that Donald Trump had experienced no symptoms following a fourteen-day course of the intestinal sickness sedate, which can mess heart up.

Prior this week, a different universe pioneer, Brazilian President Jair Bolsonaro, said he had tried positive for the infection and was taking hydroxychloroquine.

Bolsonaro has pushed his legislature to make the medication generally accessible and has urged Brazilians to take it both to treat COVID-19 and to forestall it.